235 related articles for article (PubMed ID: 28306392)
1. Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents.
Moisseiev E; Rudell J; Tieu EV; Yiu G
Curr Eye Res; 2017 Jul; 42(7):1059-1063. PubMed ID: 28306392
[TBL] [Abstract][Full Text] [Related]
2. ACCURACY AND PRECISION OF INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN REAL LIFE: What Is Actually in the Syringe?
Loewenstein I; Goldstein M; Moisseiev J; Moisseiev E
Retina; 2019 Jul; 39(7):1385-1391. PubMed ID: 29659411
[TBL] [Abstract][Full Text] [Related]
3. SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS.
Krauthammer M; Harel G; Moisseiev E
Retina; 2023 Mar; 43(3):514-519. PubMed ID: 36729828
[TBL] [Abstract][Full Text] [Related]
4. Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection.
Melo GB; da Cruz NFS; do Monte Agra LL; Emerson GG; Lima LH; Linkuviene V; Maia M; Farah ME; Carpenter JF; Rodrigues EB; Probst C
Acta Ophthalmol; 2021 Dec; 99(8):e1366-e1374. PubMed ID: 33890418
[TBL] [Abstract][Full Text] [Related]
5. A new syringe adaptor for intravitreal injection of premature eye.
Kimura S; Tsukamoto M; Shiode Y; Hosogi M; Morizane Y
Retina; 2013 Apr; 33(4):889-90. PubMed ID: 23481457
[No Abstract] [Full Text] [Related]
6. Silicone oil droplets in repackaged anti-vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination.
Olea JL; Gómez-Resa M; Cervera-Peris MM; Aragón JA
Eur J Ophthalmol; 2020 Jul; 30(4):774-779. PubMed ID: 30642195
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents.
Finkelstein M; Katz G; Zur D; Rubowitz A; Moisseiev E
Ophthalmologica; 2022; 245(1):34-40. PubMed ID: 34348344
[TBL] [Abstract][Full Text] [Related]
8. Prefilled syringes for intravitreal injection reduce preparation time.
Subhi Y; Kjer B; Munch IC
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034182
[TBL] [Abstract][Full Text] [Related]
9. Accuracy, Precision, and Residual Volume of Commonly Used Syringes for Intravitreal Injections and the Impact on Intraocular Pressure.
Agra LLM; Sverstad A; Chagas TA; Araújo RH; Oliveira LG; Kristianslund O; Petrovski G; Maia M; Moe MC; Jørstad ØK; Melo GB
Ophthalmol Retina; 2023 Oct; 7(10):892-900. PubMed ID: 37302655
[TBL] [Abstract][Full Text] [Related]
10. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures.
Souied E; Nghiem-Buffet S; Leteneux C; Bayer S; Derveloy A; Sagkriotis A; Becker G; Cohen SY
Eur J Ophthalmol; 2015; 25(6):529-34. PubMed ID: 26044375
[TBL] [Abstract][Full Text] [Related]
11. Deformation of Aflibercept and Ranibizumab Syringes Causes Variation in Intravitreal Injection Volume and Risks Retinal Tear Formation.
Raevis JJ; Lemire CA; Ramsey DJ; Riccobono J; Gonzalez E
Ophthalmol Sci; 2022 Dec; 2(4):100202. PubMed ID: 36531591
[TBL] [Abstract][Full Text] [Related]
12. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
13. Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits.
Cam D; Berk AT; Micili SC; Kume T; Ergur BU; Yilmaz O
Curr Eye Res; 2017 Feb; 42(2):315-322. PubMed ID: 27314606
[TBL] [Abstract][Full Text] [Related]
14. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and reproducibility of seven brands of small-volume syringes used for intraocular drug delivery.
Sampat KM; Wolfe JD; Shah MK; Garg SJ
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(4):385-9. PubMed ID: 23799792
[TBL] [Abstract][Full Text] [Related]
16. Variation in syringes and needles dead space compared to the International Organization for Standardization standard 7886-1:2018.
Cambruzzi M; Macfarlane P
Vet Anaesth Analg; 2021 Jul; 48(4):532-536. PubMed ID: 34059461
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
Khurana RN; Chang LK; Porco TC
JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
[TBL] [Abstract][Full Text] [Related]
18. Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapy.
Zehetner C; Bechrakis NE; Stattin M; Kirchmair R; Ulmer H; Kralinger MT; Kieselbach GF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3279-86. PubMed ID: 26024110
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal air bubbles following intravitreal injections: a comprehensive analysis.
Krauthammer M; Trabelsi E; Moisseiev E
Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3697-3702. PubMed ID: 34258656
[TBL] [Abstract][Full Text] [Related]
20. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
